Revalesio Corp — Form D/A

Revalesio Corp of TACOMA, WA, a company, filed a Form D amendment with the SEC on 2024-04-12. The offering totals $30.6M, of which $25.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
WILLIAM GALLACHERDirectorTACOMA, WA
Jeffrey SmithDirectorMARLBOROUGH, MA
JAMES NORDSTROMDirectorTACOMA, WA
ERIC RUSSELLDirectorTACOMA, WA
ERIC RUSSELLExecutive OfficerTACOMA, WA
GREG ARCHAMBEAUExecutive OfficerTACOMA, WA
CHRIS FIBIGERDirectorTACOMA, WA
BERT VAN DEN BERGHDirectorTACOMA, WA
BERT VAN DEN BERGHExecutive OfficerTACOMA, WA
JANE TAYLORDirectorTACOMA, WA
MATT IRELANDDirectorTACOMA, WA
Troy AlsteadDirectorGig Harbor, WA
LIAM GALLACHERDirectorCalgary, A0
TOM BUMOLDirectorTACOMA, WA
Scott WalchekDirectorSan Ramon, CA
JIM NORDSTROMDirectorTACOMA, WA
Lee HuntsmanDirectorSeattle, WA
MARSHA RUSSELLDirectorTACOMA, WA
BRUCE BUSKIRKExecutive OfficerTACOMA, WA
PATRICK CARUANADirectorTACOMA, WA
Scott WalcheckDirectorTacoma, WA
Karl BandlienDirectorTacoma, WA

Other filings by this issuer (7)

FiledFormOfferingSold
2025-12-16D/A$40.3M$38.9M
2022-06-09D$15.0M$12.0M
2020-07-22D$26.8M$20.4M
2018-06-27D$12.0M$6.0M
2016-07-05D$14.0M$14.0M
2014-05-05D$40.0M$13.5M
2012-06-19D$20.0M$10.7M

More